Navigation Links
Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer
Date:12/16/2010

ROYAL OAK, Mich., Dec. 16, 2010 /PRNewswire/ -- Beaumont Hospital radiation oncologists have launched a research study to treat men with low to intermediate risk prostate cancer with a single dose of radiation.

Alvaro Martinez, M.D., FACR, professor and chair, Oakland University William Beaumont School of Medicine, department of Radiation Oncology, Beaumont Hospitals, performed the first-in-the-world one-dose, High-Dose Rate brachytherapy procedure Nov. 29 on a man from Beverly Hills, Mich.

The study, approved by Beaumont's Human Investigation Committee, builds upon 18 years of past research by Dr. Martinez and other Beaumont radiation oncologists on ways to kill cancer cells through powerful, targeted, short-term radiation treatment.

"In the future of cancer care, less is more," says Dr. Martinez. "Patients want treatments that are safe, effective and fast with a high chance of a cure, thus allowing them to move on with their lives as soon as possible. Through our research, we are hoping to develop treatments that achieve these goals for patients."

HDR brachytherapy involves the temporary implantation of a "smart seed" – an Iridium 192 radioactive pellet about the size of grain of rice – at the prostate tumor site. This technique delivers more radiation to the prostate, increasing cancer killing probability, while minimizing radiation exposure to surrounding tissues, such as the bladder, urethra and rectum. Unlike permanent radioactive seed implants, no radioactive material is left in the patient's body, eliminating the risk of radiation exposure for partners or family members.

The entire procedure to temporarily implant the seed takes about three hours, once spinal anesthesia has been administered. Plastic needles are placed into the prostate using ultrasound guidance. The needles are then loaded with a single radiation seed through a cable attached to a computerized machine that moves the "smart seed" at precisely timed intervals along the needles. Treatment with the "smart seeds" takes about 15 minutes.

Low and intermediate risk patients who qualify for study participation include those with T1c through T2b tumors (small size with no metastasis or lymph node involvement), a Gleason score of 6 or 7 (low-intermediate cell aggressiveness) and a prostate-specific antigen score lower than 15.

For more information on the study or a consultation, call 248-551-7058 (for Beaumont Hospital, Royal Oak) or 248-964-3070 (for Beaumont Hospital, Troy).

Current methods for treating prostate cancer confined to the prostate gland include surgical removal of the prostate (radical prostatectomy); up to eight weeks of external beam radiation alone or combined with permanent seed implants or HDR brachytherapy; or permanent seed implants and/or HDR brachytherapy. The methods are about equal in effectiveness with different side effects.

In 1992, Dr. Martinez and his Beaumont colleagues were the first in the U.S. to perform HDR brachytherapy as an outpatient treatment for patients with locally-advanced prostate cancer. In 1995, he developed a four-treatment protocol over two days for patients with low to intermediate risk prostate cancer. A total of 1,045 patients with high, intermediate or low-risk prostate cancer have been treated through HDR brachytherapy research at Beaumont since 1992.

Beaumont's comprehensive cancer program combines the expertise of Beaumont Hospitals with the knowledge and experience of physicians in the Beaumont Oncology Network, the largest group of oncology specialists in the state, to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 47 Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials.

HIC study 2006-038

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Alvaro Martinez, M.D.   |   https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=43100


'/>"/>
SOURCE William Beaumont Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Beaumont Hospital Opens New Ernst Cardiovascular Center
2. Beaumont Patients 1st to get Next Generation of Radiation Treatment
3. TeleTracking Presents Conference on RTLS Hospital Asset Tracking
4. Milliman Care Guidelines® Now Used in More Than 1,000 Hospitals
5. Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Childrens Hospital of Broward General
6. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
7. Reportlinker Adds Europe Hospital Supplies Market Outlook to 2016
8. CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs
9. CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide
10. ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services
11. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
Breaking Medicine News(10 mins):